About us

All our products are certified to EU Good Manufacturing Practice (GMP) which is the highest standard that a producer must meet in order to place a medicinal product on the European market. The complete process is EU-GMP Certified, from the supply of dried cannabis flower to the processing and packaging of our finished products. This guarantees that our products consistently meet quality, safety and efficacy attributes throughout their shelf-life.This high level of quality and standardization enables prescribers and patients to achieve the desired therapeutic effect with minimal levels of potential side effects. It also enables numerous researchers in the field to achieve more robust clinical data through evidence-based methods.


Our Mission

Improving lives by providing patients with safe and consistent access to medical cannabis.


Our Vision

To become the global leader in promoting access to Medical Cannabis in a cost-effective, safe and consistent way.


Our values

Quality. Consistency. Compliance.

Learn more about our

Malta Facilities


Alphafarma Operations Ltd., Salus Europe’s processing facility in Malta has been designed and built to process a wide range of medical cannabis products.

State-of-the-art production facilities

Alphafarma Operations Ltd., Salus Europe’s processing facility in Malta has been designed and built to process a wide range of medical cannabis products. All activities have been inspected and certified by competent authorities in the regions where we operate. All materials are handled and lab-tested in line with our Quality Management System and Standard Operating Procedures to ensure that all inputs and outputs meet our rigorous quality standards. Products are manufactured in Pharma grade cleanrooms (ISO Class 8 / EU-GMP Grade D) under controlled environmental conditions and strict hygiene protocols, thus preventing contamination.Moreover, every single batch is tested against established pharmacopeial monographs to exclude the presence of harmful substances such as pesticides, heavy metals, bacterial and fungal contamination; and to validate the specified cannabinoid profiles.This ongoing commitment to Quality guarantees that we consistently deliver safe and effective products to patients and prescribers.

Learn more about our

South-Africa Facilities


First Growth, Salus Europe’s South African supply source, has a 6,292.8 sq.m greenhouse facility in the Stellenbosch region of South Africa.

First Growth, Salus Europe’s South African supply source, has a 6,292.8 sq.m greenhouse facility in the Stellenbosch region of South Africa. The facility has been granted a license to cultivation medical cannabis, under a GACP environment, by the South African Health Products Regulatory Authority (SAPHRA).First Growth benefits from prime sub-Saharan growing conditions capable of four harvest per year. The facility is currently in the process of beginning the fit out of flowering rooms in partnership with experienced greenhouse experts, cultivators and a nursery. The facility’s modular design will allow for fast, cost-effective scale-up.The harvested products from First Growth’s facility will be trimmed, dried and bulk packed in a GMP-compliant clean room environment before being sent to Salus Europe’s Malta facility for final processing and distribution.First Growth expects to send its first commercial shipments to Malta in Q2 2023.